Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism
Author:
Open Access
- 3 March 2019
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 34 (8) , 1287-1295
Abstract
The cascade of gastric cancer, a leading cause of cancer incidence and mortality, is multifactorial. Helicobacter pylori (HP) infection plays a major role in gastric cancer (GC), and there has been an accumulation of data regarding the chemopreventive effect of HP eradication. However, it remains unclear how HP infection causes GC and how HP eradication prevents GC. To clarify this issue, the following approaches were performed in this review article. First, how HP‐induced atrophic gastritis (AG) and intestinal metaplasia (IM) provoke the development of GC is shown, followed by how long HP eradication takes to induce a reversible change in AG and IM. Second, epigenetic studies of PTPN6, MOS, DCC, CRK, and VAV1 were performed in noncancerous gastric specimens in terms of HP status. Among these genes, MOS was found to be a possible surrogate marker for GC development. HP eradication decreased aberrant DNA methylation in a gene‐specific manner, and MOS played a role in metachronous gastric neoplasms. Third, transforming growth factor‐β1 (TGF‐β1) and TGF‐β1‐induced epithelial‐mesenchymal transition (EMT) markers were investigated in gastric mucosa. HP infection triggered the TGF‐β1‐induced EMT pathway and caused the emergence of GC stem cells, such as CD44v8‐10. When HP was eradicated, these two pathways were inhibited. Finally, a 2222 cohort study showed that HP eradication significantly decreased the risk of noncardiac GC. Taken together, HP eradication is effective as a primary GC prevention method, and its underlying mechanism includes reversibility of AG and IM, methylation, EMT, and stem cells.Keywords
Funding Information
- National Research Foundation (NRF) of Korea grant for the Global Core Research Center (GCRC) funded by the Korean government (2011-0030001)
This publication has 69 references indexed in Scilit:
- The benefit of mass eradication ofHelicobacter pyloriinfection: a community-based study of gastric cancer preventionGut, 2012
- Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cellsMicrobes and Infection, 2010
- Inflammation and EMT: an alliance towards organ fibrosis and cancer progressionEMBO Molecular Medicine, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- Helicobacter exploits integrin for type IV secretion and kinase activationNature, 2007
- The Epigenomics of CancerCell, 2007
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001